Schonfeld Strategic Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Sell |
|
|||||
|
2025
Q1 | $2.82M | Sell |
|
|||||
|
2024
Q4 | $2.15M | Sell |
|
|||||
|
2024
Q3 | $7.37M | Buy |
|
|||||
|
2024
Q2 | $4.74M | Sell |
|
|||||
|
2024
Q1 | $4.8M | Sell |
|
|||||
|
2023
Q4 | $8.5M | Buy |
|
|||||
|
2023
Q3 | $4.73M | Sell |
|
|||||
|
2023
Q2 | $5.41M | Buy |
|
|||||
|
2023
Q1 | $636K | Sell |
|
|||||
|
2022
Q4 | $6.51M | Buy |
|
|||||
|
2022
Q3 | $2.2M | Sell |
|
|||||
|
2022
Q2 | $1.9M | Buy |
|
|||||
|
2022
Q1 | $302K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $44K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.64M | Buy |
|
|||||
|
2020
Q1 | $742K | Sell |
|
|||||
|
2019
Q4 | $3.12M | Sell |
|
|||||
|
2019
Q3 | $2.48M | Sell |
|
|||||
|
2019
Q2 | $15.7M | Buy |
|
|||||
|
2019
Q1 | $1.77M | Buy |
|